Recent discussions on X about Morgan Stanley Direct Lending Fund (MSDL) have centered on the company’s disappointing Q2 2025 financial results, which showed earnings and revenue falling short of expectations. Many users have expressed concerns over the tight dividend coverage and the potential risks posed by interest rate fluctuations, casting doubt on the sustainability of its attractive 11%+ dividend yield. The stock’s new 1-year low has also fueled debates about its future trajectory.
Despite the challenges, some on X have pointed out positives, such as the stability of MSDL’s portfolio and the company’s decision to maintain its quarterly dividend at $0.50 per share. A few have highlighted a recent insider purchase of nearly $250,000 in stock as a potential sign of confidence in a recovery. The conversation remains dynamic as investors weigh the balance between high yield and underlying risks.
Note: This discussion summary was generated from an AI condensation of post data.
Morgan Stanley Direct Lending Fund Insider Trading Activity
Morgan Stanley Direct Lending Fund insiders have traded $MSDL stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MSDL stock by insiders over the last 6 months:
- MICHAEL JR. OCCI (Chief Executive Officer) purchased 14,000 shares for an estimated $248,851
- KEVIN SHANNON has made 3 purchases buying 10,000 shares for an estimated $194,293 and 0 sales.
- JOAN BINSTOCK purchased 5,659 shares for an estimated $100,079
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Morgan Stanley Direct Lending Fund Hedge Fund Activity
We have seen 68 institutional investors add shares of Morgan Stanley Direct Lending Fund stock to their portfolio, and 34 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 2,247,485 shares (+17.1%) to their portfolio in Q1 2025, for an estimated $44,859,800
- CLIFFWATER LLC removed 1,203,819 shares (-83.3%) from their portfolio in Q1 2025, for an estimated $24,028,227
- GENERALI ASSET MANAGEMENT SPA SGR added 880,372 shares (+99.9%) to their portfolio in Q2 2025, for an estimated $16,480,563
- UBS GROUP AG added 463,504 shares (+287.4%) to their portfolio in Q1 2025, for an estimated $9,251,539
- RENAISSANCE TECHNOLOGIES LLC removed 337,936 shares (-95.8%) from their portfolio in Q1 2025, for an estimated $6,745,202
- WELLS FARGO & COMPANY/MN added 269,954 shares (+920.8%) to their portfolio in Q1 2025, for an estimated $5,388,281
- MUZINICH & CO., INC. added 242,931 shares (+114.2%) to their portfolio in Q2 2025, for an estimated $4,547,668
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Morgan Stanley Direct Lending Fund Analyst Ratings
Wall Street analysts have issued reports on $MSDL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 05/22/2025
To track analyst ratings and price targets for Morgan Stanley Direct Lending Fund, check out Quiver Quantitative's $MSDL forecast page.
Morgan Stanley Direct Lending Fund Price Targets
Multiple analysts have issued price targets for $MSDL recently. We have seen 5 analysts offer price targets for $MSDL in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Doug Harter from UBS set a target price of $21.0 on 07/16/2025
- Kenneth Lee from RBC Capital set a target price of $21.0 on 05/22/2025
- Finian O'Shea from Wells Fargo set a target price of $19.0 on 04/28/2025
- Melissa Wedel from JP Morgan set a target price of $19.5 on 04/24/2025
- Ryan Lynch from Keefe, Bruyette & Woods set a target price of $20.0 on 04/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
